Archives

by in
Entry Author Date Location
Dunsire Out at Millennium as Takeda Reorganizes, Cuts Costs 05/09/13 Boston
Lessons For Drug Development From The Aveo Buzzsaw 05/06/13 National
Aveo’s Stock Plunges As Day of Reckoning Nears For Cancer Drug 04/30/13 Boston
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
Celgene Wins FDA Approval of Third Myeloma Drug 02/08/13 New York
Boston’s Got Big Mo in Biotech, But SF is Pushing Back 01/21/13 National
Can (Should?) A Young Biotech Company Still Go Long? 12/20/12 Boston
Onyx, Millennium, Ariad: Firms to Watch at Hematology Meeting 12/07/12 Boston
Who Are Biotech’s New Go-To Investment Bankers? 11/12/12 National
Reinventing Biotech’s Business Model: The Photos 10/18/12 San Francisco
See the Agenda for ‘Reinventing Biotech’s Business Model’ Oct. 16 in SF 10/10/12 San Francisco
See What GSK, J&J, KPCB, Third Rock & Orbimed Have in Common Oct. 16 10/03/12 San Francisco
Betting on Biotech to Catalyze U.S. Job Growth? Don’t Count On It 10/01/12 National
Bayer, Onyx Cancer Drug Wins FDA Approval Ahead of Schedule 09/27/12 San Francisco
Kinsella Redux: Charting a Way Back for Life Sciences Startups 09/27/12 San Diego
Roche Deal With Tiny Sunnyvale Biotech Revives Old Family Ties 09/25/12 San Francisco
Exelixis and Onyx Await Their Cancer-Drug Fates 09/18/12 San Francisco
Join Us Oct. 16 for ‘Reinventing Biotech’s Business Model’ in SF 09/11/12 San Francisco
Fearless Football and Biotech Picks For Fall 2012 09/04/12 National
Join Risa Stack, Tony Coles & More for ‘Reinventing Biotech’ 08/09/12 San Francisco
U.S. Biotech Clusters Are Losing Their Anchor Tenants, and It Hurts 08/06/12 National
Aveo Shares Fall as FDA Questions Cancer Drug Survival Trend 08/02/12 Boston
Onyx Gets FDA Approval For New Myeloma Drug; Stock Climbs 07/20/12 San Francisco
Onyx Shares Boom on Positive FDA Panel for Myeloma Drug 06/21/12 San Francisco
ASCO Wrap-Up: A Summary of This Week’s Cancer R&D Headlines 06/05/12 National
Promedior, Aveo, Ra, and More Boston Life Sciences Headlines 05/18/12 Boston
Aveo Kidney Cancer Drug Shows Safety Edge in Pivotal Study 05/16/12 Boston
Millennium Wins FDA OK for New Velcade, Looks to Fend Off Onyx 01/23/12 Boston
Millennium, Looking to Fend Off Onyx, Awaits FDA Word on New Velcade 01/20/12 Boston
Onyx, Bayer’s Next Cancer Drug Shows Slim Survival Edge 01/17/12 San Francisco
Page 1 of 3 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  5. Do You Need an Extended Warranty? Do the Math, Says SquareTrade

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.